Mipharm S.p.A.

Mipharm S.p.A.

Fabbricazione di prodotti farmaceutici

Milan, Lombardia 21.368 follower

FLEXIBILITY & RELIABILITY

Chi siamo

Mipharm S.p.A. was born in January 1998 following the merger of Sandoz and Ciba Geigy, from which resulted the new company Novartis. Mipharm was founded by a group of ex managers coming from Novartis by mean of a spin-off of the manufacturing site located in Milan, Via Quaranta, previously owned by Sandoz. In December 2016, Mandarin Capital Partners II acquired the majority stake in Mipharm share capital. Today, Mipharm is one of the most valuable third party manufacturing and new product development sites in Italy and it claims to have four FDA approvals (Nasal Spray Solution, Oral Potent Drug, Sachet, Packaging). Mipharm has been investing significant resources to continuously improve manufacturing site qualitative standard and currently it is able to produce and to pack a huge range of products and pharmaceutical forms.

Sito Web
http://www.mipharm.it
Settore
Fabbricazione di prodotti farmaceutici
Dimensioni dell’azienda
201-500 dipendenti
Sede principale
Milan, Lombardia
Tipo
Società privata non quotata
Data di fondazione
1998
Settori di competenza
Pharmaceuticals third party manufacturing, Special Services e Pharma

Località

Dipendenti presso Mipharm S.p.A.

Aggiornamenti

Pagine simili

Sfoglia le offerte di lavoro

Raccolta fondi

Mipharm S.p.A. 1 round in totale

Ultimo round

Private equity
Vedi altre informazioni su Crunchbase